172 related articles for article (PubMed ID: 9784507)
1. Staphylococcal enterotoxin B primes cytokine secretion and lytic activity in response to native bacterial antigens.
Mason KM; Dryden TD; Bigley NJ; Fink PS
Infect Immun; 1998 Nov; 66(11):5082-8. PubMed ID: 9784507
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel in vitro co-culture system for studying host response to native bacterial antigens.
Mason KM; Bigley NJ; Fink PS
J Immunol Methods; 1998 Feb; 211(1-2):147-58. PubMed ID: 9617839
[TBL] [Abstract][Full Text] [Related]
3. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines.
Tokura Y; Yagi J; O'Malley M; Lewis JM; Takigawa M; Edelson RL; Tigelaar RE
J Invest Dermatol; 1994 Jan; 102(1):31-8. PubMed ID: 8288908
[TBL] [Abstract][Full Text] [Related]
4. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
[TBL] [Abstract][Full Text] [Related]
5. CD8+ cells are the main producers of IL10 and IFN gamma after superantigen stimulation.
Höidén I; Möller G
Scand J Immunol; 1996 Nov; 44(5):501-5. PubMed ID: 8947602
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium bovis BCG-infected mice are more susceptible to staphylococcal enterotoxin B-mediated toxic shock than uninfected mice despite reduced in vitro splenocyte responses to superantigens.
Pedras-Vasconcelos JA; Chapdelaine Y; Dudani R; van Faassen H; Smith DK; Sad S
Infect Immun; 2002 Aug; 70(8):4148-57. PubMed ID: 12117923
[TBL] [Abstract][Full Text] [Related]
7. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
[TBL] [Abstract][Full Text] [Related]
8. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.
Rich S; Seelig M; Lee HM; Lin J
J Immunol; 1995 Jul; 155(2):609-18. PubMed ID: 7608539
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of cellular and cytokine responses in a chimeric mouse model for the study of staphylococcal enterotoxin B pathogenesis.
Yuan L; Lowell GH; Hoover DL; Colleton CA; Hammack CA; Young LD; Fischer R; Patchen ML; Cross AS
Immunol Lett; 2000 Jan; 71(1):19-26. PubMed ID: 10709781
[TBL] [Abstract][Full Text] [Related]
11. Administration of superantigens protects mice from lethal Listeria monocytogenes infection by enhancing cytotoxic T cells.
Okamoto S; Kawabata S; Nakagawa I; Hamada S
Infect Immun; 2001 Nov; 69(11):6633-42. PubMed ID: 11598032
[TBL] [Abstract][Full Text] [Related]
12. Repeated treatment with S. aureus superantigens expands the survival rate of Ehrlich ascites tumor bearing mice.
Mondal TK; Bhatta D; Biswas S; Pal P
Immunol Invest; 2002 Feb; 31(1):13-28. PubMed ID: 11990460
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcal enterotoxin B activates purified NK cells to secrete IFN-gamma but requires T lymphocytes to augment NK cytotoxicity.
D'Orazio JA; Burke GW; Stein-Streilein J
J Immunol; 1995 Feb; 154(3):1014-23. PubMed ID: 7529788
[TBL] [Abstract][Full Text] [Related]
14. Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma.
Litton MJ; Dohlsten M; Lando PA; Kalland T; Ohlsson L; Andersson J; Andersson U
Eur J Immunol; 1996 Jan; 26(1):1-9. PubMed ID: 8566049
[TBL] [Abstract][Full Text] [Related]
15. Active suppression induced by cutaneous exposure to bacterial superantigen is prevented by interleukin-12 treatment in vivo.
Saloga J; Enk AH; Becker D; Bellinghausen I; Kühn S; Knop J
Immunology; 1998 Apr; 93(4):485-92. PubMed ID: 9659219
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide regulates clonal expansion and activation-induced cell death triggered by staphylococcal enterotoxin B.
Brás A; Rodríguez-Borlado L; González-Garcia A; Martínez-A C
Infect Immun; 1997 Oct; 65(10):4030-7. PubMed ID: 9317003
[TBL] [Abstract][Full Text] [Related]
17. In vivo staphylococcal enterotoxin B (SEB)-primed murine splenocytes secrete mediators which suppress CD25(hi) expression and cell cycle progression of naive splenocytes in response to SEB in vitro.
Hsu LJ; Jan MS; Lin YS
Cell Immunol; 2000 Apr; 201(1):50-7. PubMed ID: 10805973
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of cytokine production by CD1d-restricted NKT cells in response to superantigen staphylococcal enterotoxin B exposure.
Ragin MJ; Sahu N; August A
Infect Immun; 2006 Jan; 74(1):282-8. PubMed ID: 16368982
[TBL] [Abstract][Full Text] [Related]
19. Superantigen activation and kinetics of cytokines in the Long-Evans rat.
Huang W; Koller LD
Immunology; 1998 Nov; 95(3):331-8. PubMed ID: 9824494
[TBL] [Abstract][Full Text] [Related]
20. Effect of treatments with cyclosporin A and anti-interferon-gamma antibodies on the mechanisms of immune tolerance in staphylococcal enterotoxin B primed mice.
Kuschnaroff LM; Valckx D; Goebels J; Rutgeerts O; Heremans H; Froyent G; Waer M
Scand J Immunol; 1997 Nov; 46(5):459-68. PubMed ID: 9393628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
